| |
|
|
|
| Unsafe Drugs
:: Vytorin
|
VYTORIN - Ezetimibe/simvastatin is more commonly known as Vytorin or Inegy. It is a combination of the statin Zocor and the cholesterol-lowering drug Zetia, which is marketed as a joint venture by the pharmaceutical giants Merck & Co. and Schering-Plough. It was first introduced to the market as a method to block cholesterol build up and the absorption of cholesterol in the system. It is proclaimed to inhibit the enzyme HMG-CoA reductase required by the body to create cholesterol, though recent studies seriously question the drug's effectiveness.
Side effects of Vytorin are myopathy (muscle weakness), myalgia (muscle pain), Rhabdomyolysis (a breakdown of skeletal tissues), abdominal pain, hepatitis, angeioedema (swelling of the skin, underlying tissues, and mucous membranes), fatigue, eczema, headaches, depression, or upper respiratory infections. In recent studies, serious links to cancer have been attributed to Vytorin as well as a connection to fatal heart failure due to a narrowing of the aortic valve. When taking Vytorin, it is important to be alert for signs of an allergic reaction that causes angeioedema. Swelling of the face, nasal passages, or throat can accelerate into a deadly emergency in minutes and needs to be dealt with swiftly.
Many of the known side effects of Vytorin can create major difficulties in the everyday lives of the patients who use it. Job loss, family stress, loss of relationships, neglect, and other issues affecting patients who take this drug have a tremendous impact on the quality of life they and their families lead. The fatal side effects of Vytorin cause serious grief and distress to family members and may leave them without not only a father or mother, or husband or wife, but a provider as well.
If you or a loved one have taken the prescription drugs Vytorin or Inegy, and have been diagnosed with cancer or suffered a heart condition possibly associated with Vytorin or Inegy, it is important to seek legal counsel immediately. Litigating cases against powerful pharmaceutical companies is complex and expensive. You need expert advice and guidance for a successful outcome.
Fill out the form below for a free evaluation by a law firm that has the resources and experience handling unsafe pharmaceutical cases.
Keywords: Vytorin Lawsuit | Vytorin Attorney | Vytorin Lawyer | Vytorin Attorneys | Vytorin Lawyers
|
| Free Case Evaluation |
Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.
|
| Vytorin In the News |
Impax Laboratories Confirms Patent Challenge Relating to VYTORIN(R), 10 mg/80 mg - MarketWatch (press release)
Impax Laboratories Confirms Patent Challenge Relating to VYTORIN(R), 10 mg/80 mgMarketWatch (press release)... is approved by FDA, Global Pharmaceuticals, Impax's generic division, will commercialize the products....
More Information »
Impax Laboratories challenges Vytorin patents - Trading Markets (press release)
Impax Laboratories challenges Vytorin patentsTrading Markets (press release)Impax filed its abbreviated new drug application (ANDA) containing a paragraph IV certification for a generic version of Vytorin with the FDA....
More Information »
Impax challenges Vytorin patent - Cardiovascular Business
Impax challenges Vytorin patentCardiovascular Business... drug Vytorin, and has filed an abbreviated new drug application to the FDA that contains language seeking to certify a generic version of the drug. ...and...
More Information »
Why Pfizer Should Keep Raising The Price Of Viagra - Forbes (blog)
Why Pfizer Should Keep Raising The Price Of ViagraForbes (blog)This has helped cushion the decline in use for Merck's Zetia and Vytorin due to accusations that their cholesterol-lowering ability might not translate into...
More Information »
The GREAT CHOLESTEROL MYTH - OpEdNews
The GREAT CHOLESTEROL MYTHOpEdNewsThe fact that statins, brand names Crestor, Lescol, Lipitor, Mevacor, Pravachol, Vytorin, and Zocor, are not the heart disease preventing wonder drugs that ...and more »
More Information »
These Cold Stocks Are Heating Up - Motley Fool
These Cold Stocks Are Heating UpMotley FoolNow the generic drug maker wants to go after Vytorin, the high cholesterol treatment from Schering Plough. For the 12 months ending in June, it's estimated ...and...
More Information »
Stock Market News for August 24, 2010 - InvestorIdeas.com (press release) (blog)
Stock Market News for August 24, 2010InvestorIdeas.com (press release) (blog)... 1.5% after it filed a patent suit against Impax Labs (NASDAQ:IPXL - Snapshot Report), which is seeking FDA approval to sell Vytorin's...
More Information »
|
|
| |